Watch Alissa Reporter in action: https://bit.ly/4axvTZ3
Agilent Diagnostics & Genomics Solutions
Biotechnology Research
Santa Clara, California 21,538 followers
Trusted Answers
About us
Pathology, genomics, CDx, & nucleic acid synthesis solutions for diagnostics, clinical & research applications in cancer, inherited, and infectious disease
- Website
-
http://www.agilent.com/
External link for Agilent Diagnostics & Genomics Solutions
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Santa Clara, California
- Specialties
- genomics, QC, nucleic acid synthesis, diagnostics, CDx, IHC, electrophoresis, genetics, cancer, preimplantation genetics, NGS, target enrichment, Pathology, Nucleic Acid, Clinical, inherited disease, infectious disease, and Microarray
Updates
-
Advance precision #oncology by performing comprehensive #genomic profiling of solid tumor samples to detect key classes of somatic mutations with the Agilent Technologies SureSelect Cancer CGP assay. Start with input as low as 10 ng. Watch the video to learn more! https://bit.ly/3Q0NEr4
-
We are excited to announce that the Agilent Technologies GenetiSure Dx Postnatal assay has achieved IVDR Class C Certification. This certification ensures that the assay meets the rigorous standards established by the In Vitro Diagnostic Regulation (IVDR) and ensures its continued availability to clinical geneticists and other healthcare professionals across the European Union. For more details, please refer to the official press release. 🌟 https://bit.ly/4b3VJUl
-
Don’t miss ABRF 2024 Annual Meeting in Minneapolis, MN! Stop by Booth #306 to discover the latest Agilent innovations and connect with our experts in the field. Find out more and register below. https://bit.ly/3IzV1St #Booth306 #ABRF2024
-
Dr. Hemad Yasaei is excited to meet you at PMES. Register now to our symposium to learn more about an automated, walkaway NGS workflow to help researchers investigate rare genetic diseases and cancer with the Magnis NGS Prep system. Click here for more information: https://bit.ly/3U1jGVe #Automation #Agilent #PMES2024
-
Interested in exploring Agilent solutions in advancing research in precision medicine? Dr. Charbel Souaid will present More insights into SureSelect Cancer CGP Assay at our symposium at #PMES. Join us to learn how these advancements are reshaping cancer research. Learn more at https://bit.ly/3U1jGVe #Agilent #PMES2024 #Sureselectcancer
-
Don’t delay your tech upgrade. Join us for our upcoming workshop and learn how the advanced automated electrophoresis platforms perform in terms of hardware, software, and assays as well as workflows. Book your calendar for April 30th at 15:00 CET and don’t forget to register here: https://bit.ly/4a7VWVT #Genomics #AutomatedElectrophoresis #TechUpgrade
-
Featuring globally curated, pan-cancer content across 679 genes, the Agilent Technologies SureSelect Cancer CGP assay enables you to detect multiple #biomarkers through comprehenisve #genomic profiling of solid #tumor samples using as little as 10 ng of input. See how it works: https://bit.ly/3TlNEmJ
-
Watch Alissa Reporter in action: https://bit.ly/4axvTZ3
-
Amplify your assays with reliable bulk #antibodies, raw materials, and expertise. Find out how we can help: https://bit.ly/4cgpUJe #immunoassay #diagnostics